bibliographic resource 1860723 [br/1860723]
https://w3id.org/oc/corpus/br/1860723
- is a
-
- title
-
- Evaluation of the EGFR-Inhibitor Zalutumumab Given With Primary Curative (Chemo)radiation Therapy to Patients With Squamous Cell Carcinoma of the Head and Neck: Results of the DAHANCA 19 Randomized Phase 3 Trial
- publication date
-
- contributor
-
- format
-
- identifier
-
- part of
-